Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-09 · accession 0001567619-22-015481 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-10 | 2022-08-09 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +10.3K | 196.9K | +6% | +$5,065 |
| D | 2022-08-10 | 2022-08-09 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -10.3K | 157.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | M | A | 10,336 | $0.49 | 196,872 | D | — | — | (F5) Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022. (F4) Includes 130,500 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-08-09 | M | D | 10,336 | $0.00 | 157,446 | D | $0.49 · 2020-12-01 to 2027-03-20 | 10,336 Common Stock |